Pseudophakic Bullous Keratopathy
16
7
7
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (16)
PVEK Corneal Implant For Treatment of Corneal Edema
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
The Belgian Endothelial Surgical Transplant of the Cornea
The OPTIMISE Study
OCT in Fuchs' Dystrophy
The Effect of ROCK Inhibitors on Corneas of Patients With Glaucoma and Pseudophakic Bullous Keratopathy (PBK)
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
Prognosis of Posterior Lamellar Keratoplasty, an Observational Cohort Study
Endothelial Side Up Inverted Femtosecond Laser Assisted DSAEK
A Phase 1/ Phase 2 Study of TTHX1114(NM141)
Predictive Factors of Graft Detachment Following Dmek
The Effect Of Preoperative Parameters On Success After DMEK Surgery
Descemet Membrane Endothelial Keratoplasty Combined With Intraocular Lens Exchange: Sequential Versus Combined Surgery
The Postoperative Head Position as a Predictor of the Surgical Outcome After DMEK
Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema
Comparison of Corneal Grafts Cultured in Serum-free Versus Corneal Grafts Cultured in Serum Supplemented Culture Media